8:00 am Check-In & Coffee

8:50 am Chair’s Opening Remarks

Harnessing Insights from Cell & Gene Therapy Pioneers to Optimize Medical Affairs Strategies

9:00 am Industry Leader’s Fireside Chat: Overcoming Current & Future Challenges in Cell & Gene Medical Affairs

• Ike Ogbaa Former Vice President, Global Head of Medical Affairs, bluebird bio
• Sujan Sivasubramaniyam Head of Medical Affairs & Patient Advocacy, UK & Ireland, CSL Behring
• Alexander Maurer Executive Director, WW Cell Therapy Franchise Medical Lead, Bristol Myers Squibb
• Kent Christopherson Executive Director & Head of Global Medical Affairs, Orchard Therapeutics

10:00 am Morning Break & Speed Networking

Unveiling the Impact of Medical Affairs in Early-Stage Development

11:00 am Advocating for Early Integration of Medical Affairs Teams in the Pre-Launch Phase

• AiThi Sprinkle Associate Director, Medical Science Liaison, Vor Bio

11:30 am The Evolution of Medical Affairs in the Era of Cell & Gene Therapy

• Warren Rizzo Scientific & Medical Affairs Consultant, ImmPACT Bio

12:00 pm Panel Discussion: Starting with the End in Mind – Investing in Medical Affairs Early to Improve Long- Term Success

• Preeti Joshi Senior Director, Head of Medical Affairs, BlueRock Therapeutics
• Ike Ogbaa Former Vice President, Global Head of Medical Affairs, bluebird bio
• Angela Tom Senior Director, Medical Affairs, Editas Medicine
• AiThi Sprinkle Associate Director, Medical Science Liaison, Vor Bio

12:45 pm Lunch Break & Networking

Establishing & Maintaining a Treatment Network for a Cell & Gene Product

1:45 pm Medical Affairs Global Role in Establishing Efficient & Standardized Treatment Center Qualification

• Katie Snell Associate Director, Global Medical Affairs, Orchard Therapeutics

2:15 pm Roundtable Discussion: Preparing Treatment Centers to Receive & Administer Cell & Gene Therapies

3:15 pm Afternoon Break & Networking

Enhancing Cross-Functional Collaboration to Propel Innovation & Achieve Strategic Goals

3:45 pm Collaborating with Clinical Development & Clinical Operations Teams – Rethinking Our Approach to Bringing Value for Early-Stage Programs

• Jeff Haroldson Executive Director, Head of Medical Affairs, North America, Tenaya Therapeutics

4:15 pm Streamlining the Relationship Between Medical Affairs, Market Access, & Commercial Teams

4:45 pm Panel Discussion: Strategies for Enhancing Cross-Functional Collaboration

• Warren Rizzo Scientific & Medical Affairs Consultant, ImmPACT Bio
• Oscar Segurado, MD PhD Executive Director, MedicAffairs Consulting LLC
• Jeff Haroldson Executive Director, Head of Medical Affairs, North America, Tenaya Therapeutics

5:30 pm Chair’s Closing Remarks

5:35 pm End of Conference Day One